Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-17 07:00
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States 2025-01-17 03:15
BGI Genomics Empowers Brunei's National Cervical Cancer Prevention Program 2025-01-16 12:51
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2025-01-16 08:03
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference 2025-01-15 09:40
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology 2025-01-15 09:00
Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots 2025-01-15 03:56
Endogenex™ Appoints Krissy Wright as Chief Financial Officer 2025-01-14 21:32
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-14 05:43
BioCina and NovaCina Merger Bolsters Global CDMO Industry 2025-01-14 00:43
Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine 2025-01-13 22:00
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue 2025-01-13 15:12
Scintimun® Commercialization Partnership with Curium Pharma 2025-01-13 13:08
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform 2025-01-13 06:34
Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). 2025-01-11 17:07
Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution 2025-01-11 05:53
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma 2025-01-10 17:00
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform 2025-01-09 16:41
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development 2025-01-09 09:45
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu 2025-01-09 03:48
1 29 30 31 32 33 264